Learn More
Gibco™ CTS™ Vitronectin (VTN-N) Recombinant Human Protein, Truncated
CTS™ (Cell Therapy Systems) Vitronectin (VTN-N) Recombinant Human Protein provides a defined surface for feeder-free culture of human pluripotent stem cells (PSCs).
Brand: Gibco™ A27940
Additional Details : Weight : 0.00100kg
Description
- Provides a defined surface for feeder-free culture of human pluripotent stem cells (PSCs)
- When used with Essential 8™ Medium (Cat. No. A1517001), CTS™ Vitronectin has been proven to maintain pluripotency and normal growth characteristics in multiple PSC lines
- Shown to support PSC growth for >8 passages without any signs of karyotypic abnormalities and to maintain the ability of PSCs to differentiate into all three germ line lineages
- VTN-N variant of vitronectin supports human pluripotent stem cell attachment and survival better than wild-type vitronectin when used in conjunction with Essential 8 Medium (1)
- Designed for clinical research—USP Chapter 1043 considered in the design
- Animal origin–free—for reduced variability and contamination risk in PSC cultures
- Optimized—designed for use with Essential 8 Medium
- Consistent—supports seamless transition from Vitronectin
- Traceable—documentation includes COO, COA, and DMF
- Controlled—manufactured in compliance with ISO-13485:2003
Designed for clinical research
- USP Chapter 1043 has been considered in the design of CTS™ Vitronectin, and this product is the only such product labeled with 'For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration to humans or animals.'
- Harmonized documentation is provided with the product and includes a Certificate of Analysis (COA), Certificate of Origin (COO), and Drug Master File (DMF) to support regulatory filings.
Animal origin–free system
- CTS™ Vitronectin is animal origin–free at the primary level to help reduce contamination risk and variability associated with animal-origin raw materials compared to human plasma–derived vitronectin and standard basement membrane extraCTS™ (BMEs)
Optimized and defined surface
- Unlike standard basement membrane extraCTS™ (BMEs), CTS™ Vitronectin is based on the N-variant design of vitronectin (VTN-N) from the laboratory of James Thomson for use with Essential 8 Medium (1) and has been shown to support human pluripotent stem cell attachment and survival better than wild type vitronectin
- Provides an optimal environment for feeder-free pluripotent stem cell culture.
Seamless transition from bench to clinic
- PSC cultures expanded in other feeder or feeder-free systems can be transitioned to Essential 8 Medium and CTS™ Vitronectin with minimal adaptation
Manufacturing control and traceability
- CTS™ Vitronectin is manufactured at a site that is FDA registered and has an ISO13485-certified quality management system
- Full traceability documentation such as Certificate of Origin, Certificate of Analysis, and Drug Master File are available
Specifications
1 mL | |
Recombinant | |
Animal Origin-Free | |
Recombinant | |
Vitronectin |
Human | |
Supplied at a concentration of 0.9 mg/mL. Store at -80°C and protect from light. |
|
Dry Ice | |
Liquid | |
CTS™ |
Designed for clinical researchUSP Chapter 1043 has been considered in the design of CTS™ Vitronectin, and this product is the only such product labeled with For Research Use or Manufacturing of Cell, Gene, or Tissue-Based Products. CAUTION: Not intended for direct administration to humans or animals. Harmonized documentation is provided with the product and includes a Certificate of Analysis (COA) and Certificate of Origin (COO) to support regulatory filings.